Shanghai, China

John Fenyu Jin

USPTO Granted Patents = 2 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
2 patents (USPTO):

Title: Innovations by John Fenyu Jin: Pyrimidoheterocyclic Compounds

Introduction

John Fenyu Jin is an inventive mind based in Shanghai, China, who has made notable contributions to the field of organic chemistry. With a focus on pharmaceutical compounds, his work is underscored by his two patents that showcase his dedication to advancing chemical innovations.

Latest Patents

Jin's latest patents revolve around the invention of pyrimidoheterocyclic compounds, which have significant implications in the pharmaceutical industry. His inventions specifically disclose a class of these compounds, represented by formula (III), along with their pharmaceutically acceptable salts. These innovations are critical as they open avenues for new therapeutic applications.

Career Highlights

Currently, John Fenyu Jin is associated with D3 Bio (Wuxi) Co., Ltd., where he has the opportunity to apply his expertise in the development of new medicinal compounds. His work further defines the landscape of drug discovery and development within the industry.

Collaborations

In his professional journey, Jin has collaborated with talented colleagues such as Shuhui Chen and Wentao Wu. These collaborations are important for fostering innovation and pushing the boundaries of research in the field of medicinal chemistry.

Conclusion

John Fenyu Jin’s contributions to the field of pyrimidoheterocyclic compounds highlight the intersection of innovation and practical application in chemistry. His patents not only reflect his inventive spirit but also the collaborative efforts that drive advancements in pharmaceuticals. As a recognized inventor, Jin continues to pave the way for future discoveries in drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…